BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33037835)

  • 1. Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis.
    Do TM; Unis GD; Kattar N; Ananth A; McCoul ED
    Laryngoscope; 2021 Jun; 131(6):1235-1253. PubMed ID: 33037835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
    Wei J; Zhu X; Yang G; Shen J; Xie P; Zuo X; Xia L; Han Q; Zhao Y
    Brain Behav; 2019 Oct; 9(10):e01409. PubMed ID: 31541518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial.
    Burmeister J; Holle D; Bock E; Ose C; Diener HC; Obermann M
    Trials; 2015 Dec; 16():550. PubMed ID: 26634453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trigeminal Neuralgia With Extraoral Trigger Zone Successfully Treated With Intraoral Injections of Botulinum Toxin: A Case Report.
    Dinan JE; Smith A; Hawkins JM
    Clin Neuropharmacol; 2020; 43(5):162-163. PubMed ID: 32947428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C; Díaz S; Piedimonte F; Micheli F
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?
    Tereshko Y; Valente M; Belgrado E; Dalla Torre C; Dal Bello S; Merlino G; Gigli GL; Lettieri C
    Toxins (Basel); 2023 Nov; 15(11):. PubMed ID: 37999517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia.
    Allam N; Brasil-Neto JP; Brown G; Tomaz C
    Clin J Pain; 2005; 21(2):182-4. PubMed ID: 15722812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-antiepileptic drugs for trigeminal neuralgia.
    Zhang J; Yang M; Zhou M; He L; Chen N; Zakrzewska JM
    Cochrane Database Syst Rev; 2013 Dec; (12):CD004029. PubMed ID: 24297506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
    Sandrini G; De Icco R; Tassorelli C; Smania N; Tamburin S
    J Headache Pain; 2017 Dec; 18(1):38. PubMed ID: 28324318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments.
    Gambeta E; Chichorro JG; Zamponi GW
    Mol Pain; 2020; 16():1744806920901890. PubMed ID: 31908187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-antiepileptic drugs for trigeminal neuralgia.
    He L; Wu B; Zhou M
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004029. PubMed ID: 16856027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials.
    Morra ME; Elgebaly A; Elmaraezy A; Khalil AM; Altibi AM; Vu TL; Mostafa MR; Huy NT; Hirayama K
    J Headache Pain; 2016 Dec; 17(1):63. PubMed ID: 27377706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options.
    Al-Quliti KW
    Neurosciences (Riyadh); 2015 Apr; 20(2):107-14. PubMed ID: 25864062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of opioid use in patients with trigeminal neuralgia undergoing neurosurgery.
    Yang AI; McShane BJ; Hitti FL; Sandhu SK; Chen HI; Lee JYK
    J Neurosurg; 2019 Jan; 131(6):1805-1811. PubMed ID: 30641832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Trigeminal Neuralgia: An Update on Systematic Review With Meta-analyses.
    Hu X; Xia Y; Li J; Wang X; Liu H; Hu J; Bi J; Wu J; Wang T; Lin Z; Xiong N
    Clin J Pain; 2024 Jun; 40(6):383-392. PubMed ID: 38385501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U; Ilhan S; Alp R; Sur H
    Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta-analysis.
    Wang QP; Bai M
    CNS Drugs; 2011 Oct; 25(10):847-57. PubMed ID: 21936587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin in trigeminal neuralgia.
    Castillo-Álvarez F; Hernando de la Bárcena I; Marzo-Sola ME
    Med Clin (Barc); 2017 Jan; 148(1):28-32. PubMed ID: 27743594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Toxin as an Effective Treatment for Trigeminal Neuralgia in Surgical Practices.
    Tangney T; Heydari ES; Sheldon BL; Shetty A; Argoff CE; Khazen O; Pilitsis JG
    Stereotact Funct Neurosurg; 2022; 100(5-6):314-320. PubMed ID: 35944492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.